Celera Genomics Group of Rockville reports net loss of $7.1 million

Daily Record, The (Baltimore), Oct 26, 2006 by Daily Record Staff

> Celera Genomics Group, of Rockville, a drug discovery company, reported a net loss of $7.1 million, or 9 cents per diluted share, for its fiscal first quarter ended Sept. 30, compared to a net loss of $16.7 million, or 23 cents per diluted share, for the first quarter of fiscal 2006. Revenue for the fiscal first quarter was $10.2 million, compared to $9.2 million for the same period last year.